ClassID:

20158

A61K9/5068 - page 2 - CPC Classification

Classification description:

Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate; Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals; Wall or coating material; Compounds of unknown constitution, e.g. material from plants or animals Cell membranes or bacterial membranes enclosing drugs

Recent Application in this class:
#301
20170369843
2017-12-28

Synthetic membrane-receiver complexes

#302
20170327557
2017-11-16

Efficient delivery of therapeutic molecules to cells of the inner ear

#303
20170326071
2017-11-16

YEAST CELL WALL PARTICLES FOR RECEPTOR-TARGETED NANOPARTICLE DELIVERY

#304
20170304212
2017-10-26

Gene carrier using cell-derived nanovesicles and method for preparing the same

#305
20170292113
2017-10-12

Inflammation-targeted neutrophil granulocyte drug delivery system and use thereof

#306
20170267757
2017-09-21

Composition for preventing or treating lung cancer comprising antibody against CD66C and chemotherapeutic agent

#307
20170258734
2017-09-14

Bacterially derived intact minicells that encompass plasmid free DNA and methods of using the same

#308
20170224625
2017-08-10

REGULATED GENETIC SUICIDE MECHANISM COMPOSITIONS AND METHODS

#309
20170095510
2017-04-06

Use of nanoparticles coated with red blood cell membranes to treat hemolytic diseases and disorders

#310
20170079909
2017-03-23

Hydrogel toxin-absorbing or binding nanoparticles

#311
20170065532
2017-03-09

Vaccine delivery systems using yeast cell wall particles

#312
20170059572
2017-03-02

Analysis of genomic DNA, RNA, and proteins in exosomes for diagnosis and theranosis

#313
20170007688
2017-01-12

VACCINE DELIVERY SYSTEMS USING YEAST CELL WALL PARTICLES

#314
20170000729
2017-01-05

METHODS AND COMPOSITIONS FOR TREATMENT OF NEURODEGENERATIVE DISEASES

#315
20160367629
2016-12-22

Compositions and methods for delivery of bioencapsulated proteins across blood-brain and retinal barriers

#316
20160361361
2016-12-15

Method of treatment using a pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and its cofactor

#317
20160250256
2016-09-01

Tumoricidal and antimicrobial compositions and methods

#318
20160243171
2016-08-25

THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS

#319
20160228521
2016-08-11

MANAGING IMMUNE RESPONSES IN TRANSPLANTATION

#320
20160220499
2016-08-04

Bacterial ghosts as carrier and targeting vehicles

#321
20160208216
2016-07-21

METHODS OF CELL CULTURE FOR ADOPTIVE CELL THERAPY

#322
20160175251
2016-06-23

Yeast cell wall particles for receptor-targeted nanoparticle delivery

#323
20160144002
2016-05-26

Sickled Erythrocytes and Progenitors Target Cytotoxics to Tumors

#324
20160120956
2016-05-05

COMPOSITION OF ERYTHROCYTES ENCAPSULATING PHENYLALANINE HYDROXYLASE AND THERAPEUTIC USE THEREOF

#325
20160120818
2016-05-05

PHARMACEUTICAL COMPOSITIONS COMPRISING VESICLES

#326
20160113883
2016-04-28

Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

#327
20160095941
2016-04-07

Enhanced loading of intact, bacterially derived vesicles with small molecule compounds

#328
20160095884
2016-04-07

Method for stabilising suspensions of red blood cells encapsulating an active ingredient

#329
20160089344
2016-03-31

Nanoparticle targeted drug delivery to the lungs using extra-testicular sertoli cells

#330
20160051687
2016-02-25

Bacterially-derived, intact minicells that encompass plasmid-free functional nucleic acid for in vivo delivery to mammalian cells

#331
20160051482
2016-02-25

Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes

#332
20150289503
2015-10-15

Preservatives

#333
20150245997
2015-09-03

Lipid membrane structure including bacterial cell component having dispersibility in non-polar solvent, and method for producing same

#334
20150216930
2015-08-06

Extracellular vesicles comprising recombinant lysosomal transmembrane protein

#335
20150216899
2015-08-06

Exosome-based therapeutics against neurodegenerative disorders

#336
20150153341
2015-06-04

Nanoprobe and method for detecting target analyte using the same

#337
20140335047
2014-11-13

Drug delivery product and methods

#338
20140288192
2014-09-25

Dynamic bio-nanoparticle platforms

#339
20140220116
2014-08-07

Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells

#340
20140161874
2014-06-12

Process of preparation and uses of plasma membrane vesicles extracted from plants enriched in membrane transport proteins

#341
20140154797
2014-06-05

Lysis/resealing process and device for incorporating an active ingredient, in particular asparaginase or inositol hexaphosphate, in erythrocytes

#342
20130236537
2013-09-12

Pharmaceutical preparation for tumor chemotherapy and method for producing the same

#343
20130195765
2013-08-01

Method for treating and diagnosing cancer by using cell-derived microvesicles

#344
20130177499
2013-07-11

Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors

#345
20130143314
2013-06-06

THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS

#346
20130115617
2013-05-09

METHODS OF CELL CULTURE FOR ADOPTIVE CELL THERAPY

#347
20130071326
2013-03-21

UNIVERSAL CELL-DIRECTED THERANOSTICS

#348
20130065941
2013-03-14

COMPOSITIONS AND THEIR USES FOR GENE THERAPY OF BONE CONDITIONS

#349
20130045190
2013-02-21

Degradable microcapsules

#350
20120202732
2012-08-09

Modified AAV capsid polypeptides

#351
20120183572
2012-07-19

Method of making microalgal-based animal foodstuff supplements, microalgal-supplemented animal foodstuffs and method of animal nutrition

#352
20120177574
2012-07-12

MICROVESICLES DERIVED FROM NUCLEATED, MAMMALIAN CELLS AND USE THEREOF

#353
20120141425
2012-06-07

Adenovirus dodecahedron particles for delivery of pharmaceutical agents

#354
20120070376
2012-03-22

Yeast cell wall particles for receptor-targeted nanoparticle delivery

#355
20120040829
2012-02-16

BACTERIAL GHOSTS AS CARRIER AND TARGETING VEHICLES

#356
20120039929
2012-02-16

Therapy for lysosomal enzyme deficiencies

#357
20120039854
2012-02-16

Nanoparticle targeted drug delivery to the lungs using extra-testicular Sertoli cells

#358
20120034268
2012-02-09

Bacterial ghosts for mediating innate immunity

#359
20110250245
2011-10-13

Use of stinging cells/capsules for the delivery of active agents to keratinous substances

#360
20110212160
2011-09-01

CONFIGURABLE MICROSCOPIC MEDICAL PAYLOAD DELIVERY DEVICE TO DELIVER NUCLEAR SIGNALING PROTEINS TO SPECIFIC CELLS TO MANAGE DIABETES MELLITUS AND GENETIC DEFICIENCY DISORDERS

#361
20110177162
2011-07-21

Degradable microcapsules

#362
20110175245
2011-07-21

ENCAPSULATION

#363
20110135696
2011-06-09

MULTIPOTENT NEURAL CELLS

#364
20110111041
2011-05-12

Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells

#365
20110070224
2011-03-24

Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue

#366
20110020411
2011-01-27

Cystinosin replacement factor

#367
20110014171
2011-01-20

Formulation and Method for the Prevention and Treatment of Bone Metastases or Other Bone Diseases

#368
20110002984
2011-01-06

FORMULATIONS COMPRISING EXINE SHELLS

#369
20100316620
2010-12-16

Formulation and Method for the Prevention and Treatment of Skeletal Manifestation of Gaucher's Disease

#370
20100310612
2010-12-09

Medicament for the treatment of cancer of the pancreas

#371
20100221357
2010-09-02

Drug delivery product and methods

#372
20100203082
2010-08-12

Virus-modified bacteria ghosts

#373
20100112670
2010-05-06

REGULATED GENETIC SUICIDE MECHANISM COMPOSITIONS AND METHODS

#374
20100074921
2010-03-25

Carrier

#375
20100055058
2010-03-04

Use of stinging cells/capsules for the delivery of active agents to keratinous substances

#376
20100040656
2010-02-18

Compositions containing a hollow glucan particle or a cell wall particle encapsulating a terpene component, methods of making and using them

#377
20090226528
2009-09-10

Encapsulated nanoparticles for nucleic acid delivery

#378
20090214662
2009-08-27

Surface-layer protein coated microspheres and uses thereof

#379
20090209624
2009-08-20

COMPOSITIONS AND THEIR USES FOR GENE THERAPY OF BONE CONDITIONS

#380
20090098149
2009-04-16

Transgenic algae for delivering antigens to an animal

#381
20090011036
2009-01-08

Drug containing hollow protein nanoparticles of particle-forming protein, fused with disease-treating target-cell-substance

#382
20080299084
2008-12-04

Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells

#383
20080261262
2008-10-23

Lysis/resealing process and device for incorporating an active ingredient, in particular asparaginase or inositol hexaphosphate, in erythrocytes

#384
20080138877
2008-06-12

Apparatus and Method For Electroporation of Biological Samples

#385
20080124308
2008-05-29

Gene Therapy of Solid Tumours by Means of Retroviral Vectors Pseudotyped With Arenavirus Glycoproteins

#386
20080069890
2008-03-20

Method for treating patients with implants of islets which have been kept in long term, in vitro culture

#387
20080051469
2008-02-28

Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells

#388
20070298056
2007-12-27

Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells

#389
20070269417
2007-11-22

Nicotine delivery systems

#390
20070160546
2007-07-12

Use of stinging cells/capsules for the delivery of active agents to keratinous substances

#391
20070141163
2007-06-21

Smart bio-nanoparticle elements

#392
20070042005
2007-02-22

Pharmaceutical composition comprising fungal cell or fragment thereof

#393
20060270030
2006-11-30

Multimodally altered cells as a form for administering active substances and as diagnostic particles

#394
20060240114
2006-10-26

Drug for treating hemophilia and method of treating hemophilia using the same

#395
20060165726
2006-07-27

Remedies with the use of hollow protein nanoparticles presenting growth factor or the like

#396
20060165614
2006-07-27

Palatable micro-capsules

#397
20060159769
2006-07-20

Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue

#398
20060127489
2006-06-15

Targeted delivery

#399
20060121077
2006-06-08

Method for treating patients with implants of islets which have been kept in long term, in vitro culture

#400
20060120974
2006-06-08

Nicotine delivery systems

#401
20060083718
2006-04-20

Therapy for lysosomal enzyme deficiencies

#402
20060034869
2006-02-16

Drug for treating liver diseases with the use of hollow protein nanoparticles

#403
20050281840
2005-12-22

Method of making microalgal-based animal foodstuff supplements, microalgal-supplemented animal foodstuffs and method of animal nutrition

#404
20050281781
2005-12-22

Drug delivery product and methods

#405
20050181064
2005-08-18

Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith

#406
20050118273
2005-06-02

Microcapsules and oral composition containing the same

#407
20050025757
2005-02-03

Oxygen carrier system, artificial oxygen carrier, and reducing agent